LHC Group (NASDAQ:LHCG) – SunTrust Banks upped their Q3 2017 earnings estimates for LHC Group in a research note issued to investors on Thursday. SunTrust Banks analyst D. Macdonald now anticipates that the health services provider will earn $0.59 per share for the quarter, up from their previous forecast of $0.57. SunTrust Banks also issued estimates for LHC Group’s Q4 2017 earnings at $0.63 EPS, FY2017 earnings at $2.38 EPS, Q1 2018 earnings at $0.59 EPS, Q2 2018 earnings at $0.69 EPS, Q3 2018 earnings at $0.64 EPS, FY2018 earnings at $2.62 EPS and FY2019 earnings at $2.88 EPS.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 EPS for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.09. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The company had revenue of $260.20 million for the quarter, compared to analyst estimates of $254.10 million. During the same period in the prior year, the firm posted $0.52 EPS. The company’s quarterly revenue was up 15.1% on a year-over-year basis.

ILLEGAL ACTIVITY NOTICE: This story was posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/08/07/suntrust-banks-analysts-raise-earnings-estimates-for-lhc-group-lhcg.html.

Several other research firms have also recently weighed in on LHCG. Zacks Investment Research cut shares of LHC Group from a “buy” rating to a “hold” rating in a report on Thursday, July 6th. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and issued a $68.00 price target (up previously from $55.00) on shares of LHC Group in a report on Monday, May 8th. BidaskClub cut shares of LHC Group from a “buy” rating to a “hold” rating in a report on Tuesday, July 25th. Royal Bank Of Canada reiterated a “buy” rating on shares of LHC Group in a report on Tuesday, June 13th. Finally, Jefferies Group LLC lifted their price target on shares of LHC Group from $56.00 to $65.00 and gave the company a “buy” rating in a report on Monday, May 15th. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $65.75.

LHC Group (NASDAQ LHCG) opened at 60.85 on Monday. LHC Group has a 52-week low of $32.04 and a 52-week high of $69.35. The company’s 50 day moving average is $64.67 and its 200-day moving average is $56.16. The firm has a market cap of $1.08 billion, a P/E ratio of 26.92 and a beta of 0.77.

In other LHC Group news, COO Donald Dwayne Stelly sold 3,181 shares of the firm’s stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total transaction of $206,669.57. Following the completion of the transaction, the chief operating officer now owns 114,235 shares of the company’s stock, valued at $7,421,847.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Coliseum Capital Management, L sold 8,632 shares of the firm’s stock in a transaction on Friday, May 19th. The shares were sold at an average price of $60.25, for a total value of $520,078.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 682,839 shares of company stock worth $42,140,531. 14.80% of the stock is currently owned by company insiders.

Institutional investors have recently made changes to their positions in the stock. BlackRock Inc. raised its position in shares of LHC Group by 43,223.7% in the first quarter. BlackRock Inc. now owns 1,969,496 shares of the health services provider’s stock valued at $106,157,000 after buying an additional 1,964,950 shares in the last quarter. FMR LLC raised its position in shares of LHC Group by 14.1% in the first quarter. FMR LLC now owns 1,619,899 shares of the health services provider’s stock valued at $87,312,000 after buying an additional 199,849 shares in the last quarter. Vanguard Group Inc. raised its position in shares of LHC Group by 3.9% in the first quarter. Vanguard Group Inc. now owns 1,432,008 shares of the health services provider’s stock valued at $77,185,000 after buying an additional 54,279 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of LHC Group by 2.7% in the first quarter. Dimensional Fund Advisors LP now owns 1,262,316 shares of the health services provider’s stock valued at $68,039,000 after buying an additional 32,771 shares in the last quarter. Finally, Rothschild Asset Management Inc. raised its position in shares of LHC Group by 6.0% in the second quarter. Rothschild Asset Management Inc. now owns 547,540 shares of the health services provider’s stock valued at $37,172,000 after buying an additional 31,224 shares in the last quarter. 84.63% of the stock is owned by institutional investors and hedge funds.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.